IMA MED-TECH and Biopôle establish a strategic partnership to foster innovation in life sciences

  • Reading time 3 min

IMA Group announces that IMA MED-TECH, the business sector dedicated to medical assembly technologies, has entered into a corporate partnership agreement with Biopôle SA, one of Europe’s most established life sciences innovation ecosystems.

The partnership represents an important step in strengthening connections between industrial manufacturing expertise and emerging life sciences innovation. By joining the Biopôle community, IMA MED-TECH gains access to a vibrant network of companies, researchers and entrepreneurs active in biotechnology, diagnostics, advanced therapies and healthcare innovation.

The collaboration reflects IMA Group’s commitment to supporting the evolution of healthcare technologies through advanced automation, industrialisation know-how and sustainable manufacturing solutions. It also creates opportunities to engage with innovative projects at an early stage and contribute to their successful transition towards scalable production.

With decades of experience in automation and assembly technologies, IMA MED-TECH supports global customers in developing and manufacturing medical devices and pharmaceutical delivery systems through highly engineered, customised solutions.

“We are proud to partner with Biopôle SA and become part of one of Europe’s leading life sciences ecosystems. This collaboration provides IMA MED-TECH with access to a dynamic network that supports our strategic growth in biotechnology, with a focus on diagnostic and laboratory applications, cell and gene therapies, and advanced life science solutions”.
“Beyond business opportunities, this partnership fosters collaboration and innovation, creating new synergies for the development of next-generation medical devices and healthcare technologies. We are confident that joining the Biopôle ecosystem will accelerate our innovation journey while further strengthening IMA MED-TECH’s long-standing presence in the Neuchâtel region“.

Stephane Vuilleumier, CEO of the IMA MEDTECH Business Sector.

Commenting on the agreement, Nasri Nahas, CEO of Biopôle SA, stated:

“Sitting at the intersection of MedTech and automation, IMA MED-TECH brings valuable hands-on expertise in taking projects from early development through to industrialisation and high-volume production. We’re excited to make this expertise available to companies across the Biopôle ecosystem, helping them bring innovative solutions from the lab closer to market. At the same time, the partnership opens the door for IMA MED-TECH to connect with new technologies, ideas and opportunities for collaboration.”

The agreement reinforces IMA Group’s long-term strategy of collaborating with leading innovation ecosystems worldwide, supporting the development of breakthrough healthcare solutions while contributing advanced industrial capabilities that help accelerate their path to market.

Learn more about Biopôle

Related news

Explore all news